Additionally, Li et al. (2012) observed similar findings on SEMA5A in glioblastoma as we observed in regards to differentiation in human PC patient samples demonstrating that the treatment of glioblastoma cell lines with SEMA5A impaired cellular motility and promoted differentiation [11, 34]. The gene discussed is SEMA5A; the disease is glioblastoma.